SCHEMBL659243

SCHEMBL659243

c1ccc(CCCCCCc2ccccn2)nc1

nearest known ligand 0.80

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.80
NAAA Q02083 1/20 0.65
HRH3 Q9Y5N1 3/20 0.57
CYP1A2 P05177 4/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
CYP2C19 P33261 2/20 0.56
ALDH1A1 P00352 2/20 0.55
LMNA P02545 1/20 0.55
TAAR1 Q96RJ0 1/20 0.55
ALOX15 P16050 1/20 0.55
HRH4 Q9H3N8 2/20 0.55
CHRM2 P08172 1/20 0.53
CYP2D6 P10635 1/20 0.52
MAPT P10636 1/20 0.50
LIN28A Q9H9Z2 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2843489 1.00 HRH1 (0.80) HRH1NAAAHRH3CYP1A2SMN1; SMN2
SCHEMBL11734076 1.00 HRH1 (0.80) HRH1NAAAHRH3CYP1A2SMN1; SMN2
SCHEMBL31040594 1.00 HRH1 (0.80) HRH1NAAAHRH3CYP1A2SMN1; SMN2
SCHEMBL4418086 1.00 HRH1 (0.80) HRH1NAAAHRH3CYP1A2SMN1; SMN2
SCHEMBL726512 0.97 HRH1 (0.76) HRH1NAAAHRH3CYP1A2SMN1; SMN2
Hydrochloric Acid SCHEMBL5827595 0.95 HRH1 (0.73) HRH1NAAAHRH3CYP1A2SMN1; SMN2
SCHEMBL231470 0.92 HRH1 (0.69) HRH1NAAAHRH3CYP1A2SMN1; SMN2
SCHEMBL29485637 0.92 HRH1 (0.69) HRH1NAAAHRH3CYP1A2SMN1; SMN2
SCHEMBL31591272 0.91 HRH1 (0.69) HRH1NAAAHRH3CYP1A2SMN1; SMN2
SCHEMBL28566857 0.91 HRH1 (0.69) HRH1NAAAHRH3CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116903766-A Heterocyclic chitosan quaternary ammonium salt modified liquid and preparation method and application thereof 烟台泰和新材高分子新材料研究院有限公司 2023-10-20 CN claimed
CN-116769067-A Modification liquid, modification method of fabric and digital printing process 烟台泰和新材高分子新材料研究院有限公司 2023-09-19 CN claimed
US-20090215762-A1 Siloxane polymer containing tethered levofloxacin NDSU RESEARCH FOUNDATION 2009-08-27 US claimed
CN-116903766-A Heterocyclic chitosan quaternary ammonium salt modified liquid and preparation method and application thereof 烟台泰和新材高分子新材料研究院有限公司 2023-10-20 CN disclosed
CN-116769067-A Modification liquid, modification method of fabric and digital printing process 烟台泰和新材高分子新材料研究院有限公司 2023-09-19 CN disclosed
US-11697884-B2 Copper deposition in wafer level packaging of integrated circuits MACDERMID ENTHONE INC. (US) 2023-07-11 US disclosed
CN-114420633-A Copper deposition in wafer level packaging of integrated circuits 麦克德米德乐思公司 2022-04-29 CN disclosed
US-20210388519-A1 Copper Deposition in Wafer Level Packaging of Integrated Circuits MACDERMID ENTHONE INC. 2021-12-16 US disclosed
US-11124888-B2 Copper deposition in wafer level packaging of integrated circuits MACDERMID ENTHONE INC. (US) 2021-09-21 US disclosed
EP-3504186-A1 COPPER DEPOSITION IN WAFER LEVEL PACKAGING OF INTEGRATED CIRCUITS MacDermid Enthone Inc. (US) 2019-07-03 EP disclosed
US-20190148739-A1 POROUS BASE MATERIAL, POROUS ELECTRODE, CARBON FIBER PAPER, METHOD FOR MANUFACTURING CARBON FIBER PAPER, AND METHOD FOR MANUFACTURING POROUS BASE MATERIAL MITSUBISHI CHEMICAL CORPORATION (JP) 2019-05-16 US disclosed
WO-2010062822-A2 ELECTRODEPOSITION OF COPPER IN MICROELECTRONICS WITH DIPYRIDYL-BASED LEVELERS ENTHONE INC. (US) 2010-06-03 WO disclosed
US-20100126872-A1 ELECTRODEPOSITION OF COPPER IN MICROELECTRONICS WITH DIPYRIDYL-BASED LEVELERS ENTHONE, INC. (US) 2010-05-27 US disclosed
US-20090215762-A1 Siloxane polymer containing tethered levofloxacin NDSU RESEARCH FOUNDATION 2009-08-27 US disclosed
EP-1879972-A4 ANTI-FOULING MATERIALS CONTAINING POLYAMINE CROSS-LINKED POLYSILOXANES NDSU RES FOUNDATION (US) 2008-10-15 EP disclosed
EP-1879972-A1 ANTI-FOULING MATERIALS CONTAINING POLYAMINE CROSS-LINKED POLYSILOXANES NDSU Research Foundation (US) 2008-01-23 EP disclosed
US-20070042199-A1 Anti-fouling materials containing cationic polysiloxanes NDSU RESEARCH FOUNDATION 2007-02-22 US disclosed
WO-2006121937-A1 ANTI-FOULING MATERIALS CONTAINING POLYAMINE CROSS-LINKED POLYSILOXANES NDSU RESEARCH FOUNDATION (US) 2006-11-16 WO disclosed
US-5792822-A COMPRISING A METAL COMPLEXES AS ULTRAVIOLET LIGHT ADSORBER AND BLOCKING AGENT; RADIATION RESISTANCE, LIGHTWEIGHT, STABILITY; EYEGLASS LENS, CONTACT LENS, DISPLAY FILTER SEIKO EPSON CORPORATION (JP) 1998-08-11 US disclosed
EP-0201434-A1 Technical copolyether amides remaining pliable at a low temperature RHONE-POULENC CHIMIE (FR) 1986-11-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215762-A1 Siloxane polymer containing tethered levofloxacin PUF60, QARS1, SEPTIN7 HRH1 4094/4885NAAA 3019/4885HRH3 4247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.